UBS O'Connor’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-456,248
Closed -$554K 1063
2020
Q4
$554K Buy
+456,248
New +$4.03M 0.01% 480
2020
Q3
Sell
-760,000
Closed -$863K 429
2020
Q2
$863K Sell
760,000
-40,000
-5% -$396K 0.02% 292
2020
Q1
$620K Buy
+800,000
New +$7.89M 0.01% 254

Other funds holding TLMD

UBS O'Connor's TLMD Position: Q1 2021 in Review

UBS O'Connor sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q1 2021, closing a stake of 750,000 shares — an estimated $5.88M sold.

UBS O'Connor first reported a position in TLMD in Q1 2020 and held it in 4 quarters. The position peaked at $16.7M in Q1 2020. 64 funds tracked by Wall St. Rank hold TLMD as of Q1 2021.

  • UBS O'Connor reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 750,000 SOC Telemed, Inc. Class A Common Stock shares in Q1 2021, an estimated $5.88M.
  • UBS O'Connor first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 4 quarters.
  • UBS O'Connor's SOC Telemed, Inc. Class A Common Stock position peaked at $16.7M in Q1 2020.
  • 64 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.